Minerva Neurosciences, Inc. Gains 69.27%

Wed, Jun 28, 2023 at 07:40 PM
Minerva Neurosciences, Inc. Gains 69.27%

Minerva Neurosciences, Inc. (NERV:NASDAQ) shot up at $10.19, representing a gain of 69.3%. On Wed, Jun 28, 2023, NERV:NASDAQ hit a New 2-Week High of $10.19. The stock got featured on our News Catalysts scanner on Wed, Jun 28, 2023 at 11:23 AM in the 'PRIVATE PLACEMENT' category. From Wed, Jun 14, 2023, the stock recorded 11.11% Up Days and 30.00% Green Days

About Minerva Neurosciences, Inc. (NERV:NASDAQ)

Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It is engaged in the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system, or CNS, diseases.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.